Systematic literature review assessing the overall costs and societal impacts of moderate‐to‐severe atopic dermatitis in Europe

M Augustin, L Misery, L von Kobyletzski… - Journal of the …, 2022 - Wiley Online Library
Atopic dermatitis (AD) is a chronic inflammatory disease, driven by type 2 inflammation. The
condition manifests as moderate‐to‐severe disease in approximately 20% of adults with AD …

Airways Type-2 Related Disorders: Multiorgan, Systemic or Syndemic Disease?

F Giombi, GM Pace, F Pirola, M Cerasuolo… - International Journal of …, 2024 - mdpi.com
Chronic rhinosinusitis (CRS) has recently undergone a significant paradigm shift, moving
from a phenotypical classification towards an “endotype-based” definition that places more …

Dupilumab with concomitant Janus kinase inhibitor: a novel treatment strategy for atopic dermatitis with poor response to dupilumab

N Yang, L Chen, J Shao, F Jiang… - British Journal of …, 2022 - academic.oup.com
1 Has C, Bauer JW, Bodemer C et al. Consensus reclassification of inherited epidermolysis
bullosa and other disorders with skin fragility. Br J Dermatol 2020; 183: 614–27. 2 Kligys KR …

[HTML][HTML] Are behavioral interventions a better choice for atopic dermatitis patients? A meta-analysis of 6 randomized controlled trials

W Zhong, W Li, G Wu - Anais Brasileiros de Dermatologia, 2024 - Elsevier
Background The treatment for atopic dermatitis (AD) has been the focus of clinical research,
and behavioral intervention is considered an indispensable treatment method. To our …

Recent Advances of Basophils in Pruritic Skin Diseases

W Liu, R Xu, F Wang - Journal of Investigative Dermatology, 2023 - Elsevier
Basophils are a rare type of granulocyte in peripheral blood. Owing to their accessibility in
circulation and similarities to mast cells, basophils were considered a tool to gain insight into …

[PDF][PDF] Probiotics for atopic dermatitis

N Boutrid, H Rahmoune - Clinical Medicine, 2021 - rcpjournals.org
Editor–We read with great attention the holistic and exhaustive review by Plant and Ardern-
Jones about atopic dermatitis. 1 However, we think that the increasing use of probiotics in …

Comparison of efficacy and safety of topical tacrolimus vs. narrowband ultraviolet B for moderate-severe atopic eczema

A Bano, M Rana, ZS Suleri, M Javed… - Journal of Pakistan …, 2023 - jpad.com.pk
Objective To compare the efficacy and safety of topical tacrolimus with narrowband
ultraviolet B for moderate-severe atopic eczema. Methods 60 subjects, equally divided into …

COVID-19 multidisciplinary working group

A Gulati, J Odum, B Mckaig, H Ward, J Cotton… - Clinical …, 2021 - rcpjournals.org
7 Xu W, Barrientos T, Mao L et al. Lethal cardiomyopathy in mice lacking transferrin receptor
in the heart. Cell Rep 2015; 13: 533–45. 8 Alexandre L, Manning C, Chan SS. Prevalence of …

[HTML][HTML] New wine in old skins

A Emmanuel - Clinical Medicine, 2021 - ncbi.nlm.nih.gov
DOI: 10.7861/clinmed. ed. 21.3. 1 The update for this edition begins with our CME topic,
dermatology. An often-overlooked specialty (except before MRCP examinations), it remains …

[HTML][HTML] УСТОЙЧИВОСТЬ ЖИЗНЕННОГО МИРА ПАЦИЕНТОВ С АТОПИЧЕСКИМ ДЕРМАТИТОМ КАК ПРЕДИКТОР РЕЦИДИВОВ ЗАБОЛЕВАНИЯ

СС Тактаракова, ИО Логинова… - Психология …, 2023 - cyberleninka.ru
Обоснование. В России и за рубежом за время последнего пятидесятилетия
фиксируется рост числа пациентов с одним из наиболее распространенных …